A Study Of Significance of Risk Assesment In  Cardiovascular disease

Author(s)	Mr. Shaik Ummar Sharief, Dr.v.Satyanarayana, B.Sowjanya, D.Abhishekh, M.Nandini
Country	India
Abstract	Due to poor diet and lifestyle choices that negatively impact people's health, cardiovascular diseases (CVDs) are the major cause of death and morbidity in India. CVD rates are expected to rise in the future due to a lack of knowledge and preventive measures. One tactic to lessen the risk of CVD is to take a combo pill (Simvastatin, Lisinopril, Hydrochlorothiazide, Aspirin), which contains antiplatelet, cholesterollowering, and blood pressure-lowering agents, respectively. Methodology: Participants who have at least one risk of CVD (dyslipidemia or hypertension) are chosen, and they are given the combo medication once daily for eight weeks. Once a week, their lipid profiles, ECG, blood pressure, and other parameters are taken for analysis. Results & Conclusion: The combination pill's effectiveness was evaluated by looking at how much it reduced TG, TC, LDL-C, and blood pressure while simultaneously raising HDL levels. Consequently, it was discovered that the combo pill had the highest level of safety with the fewest possible adverse effects, making it effective in treating individuals with hypertension, dyslipidemia, or coronary artery disease.
Keywords	: Cardiovascular disease, Dyslipidemia, Hypertension, Combination pill
Field	Medical / Pharmacy
Published In	Volume 8, Issue 2, March-April 2026
Published On	2026-04-12

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research